GeneFerm Biotechnology Co., Ltd.   Report issue

For profit
Founded: Taipei City Taiwan (1999)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2007
NCT00749801
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

nattokinase (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1